BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10856813)

  • 1. In vitro and in vivo efficacy of lasalocid for treatment of experimental cryptosporidiosis.
    Castro Hermida JA; Freire Santos F; Oteiza López AM; Vergara Castiblanco CA; Ares-Mazás ME
    Vet Parasitol; 2000 Jul; 90(4):265-70. PubMed ID: 10856813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected activity of beta-cyclodextrin against experimental infection by Cryptosporidium parvum.
    Castro-Hermida JA; Freire-Santos F; Oteiza-Löpez AM; Ares-Mazás E
    J Parasitol; 2000 Oct; 86(5):1118-20. PubMed ID: 11128490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapeutic effect of azithromycin and lasalocid on Cryptosporidium infection in mice.
    Kimata I; Uni S; Iseki M
    J Protozool; 1991; 38(6):232S-233S. PubMed ID: 1667931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cryptosporidiosis in newborn calves in Ankara region: clinical, haematological findings and treatment with Lasalocid-NA].
    Sahal M; Karaer Z; Yasa Duru S; Cizmeci S; Tanyel B
    Dtsch Tierarztl Wochenschr; 2005 Jun; 112(6):203-8, 210. PubMed ID: 16028484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo efficacy of alpha-cyclodextrin for treatment of experimental cryptosporidiosis.
    Castro-Hermida JA; Ares-Mazás ME
    Vet Parasitol; 2003 Jun; 114(4):237-45. PubMed ID: 12809750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Putative anticryptosporidial agents tested with an immunodeficient mouse model.
    Leitch GJ; He Q
    Antimicrob Agents Chemother; 1994 Apr; 38(4):865-7. PubMed ID: 8031061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of two commercial disinfectants on the viability and infectivity of Cryptosporidium parvum oocysts.
    Castro-Hermida JA; Pors I; Méndez-Hermida F; Ares-Mazás E; Chartier C
    Vet J; 2006 Mar; 171(2):340-5. PubMed ID: 16490718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunosuppressed rat model for evaluation of anti-Cryptosporidium activity of sinefungin.
    Brasseur P; Favennec L; Leméteil D; Roussel F; Ballet JJ
    Folia Parasitol (Praha); 1994; 41(1):13-6. PubMed ID: 8050749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of beta-cyclodextrin against experimental cryptosporidiosis in neonatal lambs.
    Castro-Hermida JA; González-Losada Y; Freire-Santos F; González-Warleta M; Mezo-Menéndez M; Ares-Mazás E
    J Parasitol; 2002 Feb; 88(1):185-7. PubMed ID: 12053962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New potential therapies for cryptosporidiosis: an analysis of variables affecting drug efficacy.
    Rehg J
    Folia Parasitol (Praha); 1994; 41(1):23-6. PubMed ID: 8050751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with beta-cyclodextrin of natural Cryptosporidium parvum infections in lambs under field conditions.
    Castro-Hermida JA; Quílez-Cinca J; López-Bernad F; Sánchez-Acedo C; Freire-Santos F; Ares-Mazás E
    Int J Parasitol; 2001 Aug; 31(10):1134-7. PubMed ID: 11429179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Cryptosporidium parvum infection and pattern of oocyst shedding in calves in Japan.
    Uga S; Matsuo J; Kono E; Kimura K; Inoue M; Rai SK; Ono K
    Vet Parasitol; 2000 Dec; 94(1-2):27-32. PubMed ID: 11078941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with agmatine inhibits Cryptosporidium parvum infection in infant mice.
    Moore D; Waters WR; Wannemuehler MJ; Harp JA
    J Parasitol; 2001 Feb; 87(1):211-3. PubMed ID: 11227893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viability of Cryptosporidium parvum oocysts: correlation of in vitro excystation with inclusion or exclusion of fluorogenic vital dyes.
    Campbell AT; Robertson LJ; Smith HV
    Appl Environ Microbiol; 1992 Nov; 58(11):3488-93. PubMed ID: 1482174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive and therapeutic efficacy of halofuginone-lactate against Cryptosporidium parvum in spontaneously infected calves: a centralised, randomised, double-blind, placebo-controlled study.
    Klein P
    Vet J; 2008 Sep; 177(3):429-31. PubMed ID: 17606389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of two dinitroanilines against Cryptosporidium parvum in vitro and in vivo in neonatal mice and rats.
    Armson A; Sargent K; MacDonald LM; Finn MP; Thompson RC; Reynoldson JA
    FEMS Immunol Med Microbiol; 1999 Nov; 26(2):109-13. PubMed ID: 10536296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticryptosporidial activity of lasalocid and other ionophorous antibiotics in immunosuppressed rats.
    Rehg JE
    J Infect Dis; 1993 Dec; 168(6):1566-9. PubMed ID: 8245548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of beta-cyclodextrin against natural infections of cryptosporidiosis in calves.
    Castro-Hermida JA; González-Losada Y; Freire-Santos F; Mezo-Menéndez M; Ares-Mazás E
    Vet Parasitol; 2001 Nov; 101(2):85-9. PubMed ID: 11587837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of Cryptosporidium parvum oocysts under various environmental pressures.
    Robertson LJ; Campbell AT; Smith HV
    Appl Environ Microbiol; 1992 Nov; 58(11):3494-500. PubMed ID: 1482175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.